Miquel Serra‐Burriel

Also affiliated with Prevention Institute

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study”.

The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102087

N/A

0DataRank · unranked

16 citations

Gellért Perényi, Yannic Laube, Aaron Philip Mitchell, Kerstin Noëlle Vokinger, Miquel Serra‐Burriel